Resmed (RMD) Total Debt Growth (1y) (2011 - 2026)
Powered by 
Analysis
Resmed (RMD) Total Debt Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | 142.67% |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | -1.59% |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | -9.88% |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | 8.95% |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | 0.12% |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | - |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 35.55% |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | -9.07% |
| 10 | Steris | 20.01 Bn | 19.54 Bn | 684.20 Mn | 12.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.55% |
| Mar 31, 2026 | 35.30% |
| Dec 31, 2025 | 35.31% |
| Sep 30, 2025 | 35.07% |
| Jun 30, 2025 | -5.43% |
| Mar 31, 2025 | -32.84% |
| Dec 31, 2024 | -44.79% |
| Sep 30, 2024 | -49.88% |
| Jun 30, 2024 | -50.58% |
| Mar 31, 2024 | -36.28% |
| Dec 31, 2023 | -31.70% |
| Sep 30, 2023 | 70.30% |
| Jun 30, 2023 | 84.81% |
| Mar 31, 2023 | 130.38% |
| Dec 31, 2022 | 161.64% |
| Sep 30, 2022 | -1.52% |
| Jun 30, 2022 | 17.65% |
| Mar 31, 2022 | -6.78% |
| Dec 31, 2021 | -17.40% |
| Sep 30, 2021 | -23.47% |